116 related articles for article (PubMed ID: 20169770)
1. Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.
Hader WJ
Can J Neurol Sci; 2010 Jan; 37(1):28-35. PubMed ID: 20169770
[TBL] [Abstract][Full Text] [Related]
2. Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan.
Hader WJ; Yee IM
Neurology; 2007 Sep; 69(12):1224-9. PubMed ID: 17875910
[TBL] [Abstract][Full Text] [Related]
3. Disability profile of MS did not change over 10 years in a population-based prevalence cohort.
Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Rodriguez M
Neurology; 2004 Feb; 62(4):601-6. PubMed ID: 14981177
[TBL] [Abstract][Full Text] [Related]
4. The natural history of multiple sclerosis: a regional study with some longitudinal data.
Miller DH; Hornabrook RW; Purdie G
J Neurol Neurosurg Psychiatry; 1992 May; 55(5):341-6. PubMed ID: 1602305
[TBL] [Abstract][Full Text] [Related]
5. The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Tedeholm H; Skoog B; Lisovskaja V; Runmarker B; Nerman O; Andersen O
J Neurol; 2015 May; 262(5):1148-63. PubMed ID: 25712541
[TBL] [Abstract][Full Text] [Related]
6. Clinical course of multiple sclerosis: A nationwide cohort study.
Manouchehrinia A; Beiki O; Hillert J
Mult Scler; 2017 Oct; 23(11):1488-1495. PubMed ID: 27956559
[TBL] [Abstract][Full Text] [Related]
7. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.
Weinshenker BG; Bass B; Rice GP; Noseworthy J; Carriere W; Baskerville J; Ebers GC
Brain; 1989 Feb; 112 ( Pt 1)():133-46. PubMed ID: 2917275
[TBL] [Abstract][Full Text] [Related]
8. [Prognostics factors of renal failure in multiple sclerosis].
Viart L; Elalouf V; Petit J; Al Khedr A; Kristkowiak P; Saint F
Prog Urol; 2012 Dec; 22(16):1026-32. PubMed ID: 23178100
[TBL] [Abstract][Full Text] [Related]
9. Relapses and progression of disability in multiple sclerosis.
Confavreux C; Vukusic S; Moreau T; Adeleine P
N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
[TBL] [Abstract][Full Text] [Related]
10. Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis.
Masera S; Cavalla P; Prosperini L; Mattioda A; Mancinelli CR; Superti G; Chiavazza C; Vercellino M; Pinessi L; Pozzilli C
Mult Scler; 2015 Sep; 21(10):1291-7. PubMed ID: 25533293
[TBL] [Abstract][Full Text] [Related]
11. Change in MS-related disability in a population-based cohort: a 10-year follow-up study.
Pittock SJ; Mayr WT; McClelland RL; Jorgensen NW; Weigand SD; Noseworthy JH; Weinshenker BG; Rodriguez M
Neurology; 2004 Jan; 62(1):51-9. PubMed ID: 14718697
[TBL] [Abstract][Full Text] [Related]
12. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
[TBL] [Abstract][Full Text] [Related]
13. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study.
Manouchehrinia A; Tench CR; Maxted J; Bibani RH; Britton J; Constantinescu CS
Brain; 2013 Jul; 136(Pt 7):2298-304. PubMed ID: 23757766
[TBL] [Abstract][Full Text] [Related]
14. Excess Mortality in Patients with Multiple Sclerosis Starts at 20 Years from Clinical Onset: Data from a Large-Scale French Observational Study.
Leray E; Vukusic S; Debouverie M; Clanet M; Brochet B; de Sèze J; Zéphir H; Defer G; Lebrun-Frenay C; Moreau T; Clavelou P; Pelletier J; Berger E; Cabre P; Camdessanché JP; Kalson-Ray S; Confavreux C; Edan G
PLoS One; 2015; 10(7):e0132033. PubMed ID: 26148099
[TBL] [Abstract][Full Text] [Related]
15. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process.
Confavreux C; Vukusic S; Adeleine P
Brain; 2003 Apr; 126(Pt 4):770-82. PubMed ID: 12615637
[TBL] [Abstract][Full Text] [Related]
16. The natural history of early versus late disability accumulation in primary progressive MS.
Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
[TBL] [Abstract][Full Text] [Related]
17. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
Cottrell DA; Kremenchutzky M; Rice GP; Koopman WJ; Hader W; Baskerville J; Ebers GC
Brain; 1999 Apr; 122 ( Pt 4)():625-39. PubMed ID: 10219776
[TBL] [Abstract][Full Text] [Related]
18. Late-onset multiple sclerosis.
Polliack ML; Barak Y; Achiron A
J Am Geriatr Soc; 2001 Feb; 49(2):168-71. PubMed ID: 11207871
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a two-stage disability progression in multiple sclerosis.
Leray E; Yaouanq J; Le Page E; Coustans M; Laplaud D; Oger J; Edan G
Brain; 2010 Jul; 133(Pt 7):1900-13. PubMed ID: 20423930
[TBL] [Abstract][Full Text] [Related]
20. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
D'hooghe MB; Haentjens P; Nagels G; De Keyser J
Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
